“Oppenheimer: These 3 Penny Stocks Have Triple-Digit Upside Potential”
September 2, 2020
“Baudax Bio (BXRX)
First up we have Baudax Bio, which is a pharmaceutical company focused on developing and commercializing innovative products for acute care settings. With shares changing hands for $2.80, Oppenheimer believes that the share price presents an attractive entry point…
aTyr Pharma (LIFE)
Using an innovative approach, aTyr Pharma translates biology into cutting-edge therapies designed to improve patient outcomes. Given the resumption of some of its clinical activity and its $3.67 share price, it’s no wonder Oppenheimer is pounding the table…
Amyris Inc. (AMRS)
Amyris, which engineers, manufactures and sells sustainably sourced products into the Health & Wellness, Clean Skincare and Flavors & Fragrances markets, takes the last spot on our list. Based on its impressive bio-manufacturing platform and $3.38 share price, Oppenheimer thinks it’s time for investors to get in on the action…”
https://finance.yahoo.com/news/oppenheimer-3-penny-stocks-triple-193042532.html
My recommendations are always around 30 cents or under but it’s good to read other people’s opinions on penny stocks. You never know where you will find your next hot lead on a stock.